Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-5h8w5fwPhase 3Not yet recruiting
Phase 3, randomised, triple-blind trial of dexamethasone, etoricoxib and amoxicillin in Impacted lower third molar (4 arms), sponsored by Federal University of Rio de Janeiro. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-5h8w5fw.